Aidapak Services has announced it is conducting a nationwide voluntary recall of all repackaged pharmaceuticals after learning of the potential cross contamination of non-penicillin drug products repackaged in the same facility, according to a news release.
The company said there is potential likelihood that a serious anaphylactic reaction in patients, with known hypersensitivity to beta-lactam or penicillin products, could result from receiving these products.
To view a list of all products affected by this recall, click here (pdf).
There have been no reports of injuries reported to date, according to the release.
View the news release, hosted on the FDA website, about the recall by Aidapak Services.
Related Articles on Other Recent Recalls:
Boston Scientific Recalls iCross Coronary Catheters for Ultrasound Imaging
Beckman Coulter Recalls Ion Selective Electrolyte Flow Cell
Recalled Wipes Used at 25% of Veterans Affairs Medical Centers